HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Hematology1 paper

Chronic idiopathic thrombocytopenic purpura

Last edited: 4/15/2026

Overview

Chronic idiopathic thrombocytopenic purpuria (ITP) is a hematologic disorder characterized by persistent low platelet counts due to immune-mediated platelet destruction, without an identifiable cause 1.

Diagnosis

  • Clinical Presentation: Recurrent mucocutaneous bleeding, petechiae, and bruising 1.
  • Laboratory Tests: Platelet count <100,000/μL, peripheral blood smear showing isolated thrombocytopenia, normal bone marrow examination 1.
  • Exclusion of Secondary Causes: Rule out other causes of thrombocytopenia through comprehensive evaluation including autoimmune disorders, medications, and malignancies 1.

    • Management

  • First-Line Treatments:
    • - Corticosteroids: Prednisone, initiating dose typically 1-2 mg/kg/day 1. - Intravenous Immune Globulin (IVIG): Single dose of 400 mg/kg for rapid platelet increase 1.
  • Second-Line Treatments:
    • - Thrombopoietin Receptor Agonists (TPO-RAs): Romiplostim (dose adjusted to achieve target platelet count), Eltrombopag (typically 50-75 mg/day) 1. - Splenectomy: Considered in refractory cases unresponsive to medical therapy 1.

    Special Populations

  • Pregnancy: Management requires careful consideration of maternal and fetal safety; options include observation, corticosteroids, IVIG, and TPO-RAs 1.
  • Pediatrics: Similar treatment approaches as adults, with emphasis on minimizing long-term corticosteroid effects 1.
  • Elderly: Increased risk of complications; treatment tailored to individual risk factors, often favoring less invasive options 1.
  • Comorbidities: Management adjusted based on comorbidities; careful monitoring for drug interactions and side effects 1.

    • Key Recommendations

  • Initiate treatment with corticosteroids or IVIG for acute bleeding or severe thrombocytopenia (Evidence: Strong) 1.
  • Consider thrombopoietin receptor agonists for persistent thrombocytopenia unresponsive to initial therapy (Evidence: Moderate) 1.
  • Evaluate and manage ITP in pregnancy with multidisciplinary care to balance maternal and fetal outcomes (Evidence: Moderate) 1.

    • References

    1 Geary RC, Marks VJ. Idiopathic pigmented purpuric eruption with palmar-plantar involvement. Cutis 1987. link

    Original source

    1. [1]
      Idiopathic pigmented purpuric eruption with palmar-plantar involvement. — Geary RC, Marks VJ Cutis (1987)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG